T. Chang

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs

Hongtuan Zhang, Yong Xu, Dongze Liu, 2022, Frontiers in Immunology.

MiR-96-5p induced NDRG1 deficiency promotes prostate cancer migration and invasion through regulating the NF-κB signaling pathway.

Hongtuan Zhang, Xiaoming Wang, Ranlu Liu, 2022, Cancer biomarkers : section A of Disease markers.

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma

Hongtuan Zhang, Yong Xu, Dongze Liu, 2022, Frontiers in Genetics.

Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer

Yuchen Jiang, Ranlu Liu, Zheng D. Liang, 2022, Frontiers in Oncology.

Combination with vorinostat enhances the antitumor activity of cisplatin in castration‐resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH

Ranlu Liu, Yanming Wang, Xiao-fei Wen, 2022, The Prostate.

Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver

S. Yeh, Chawnshang Chang, Soo Ok Lee, 2014, Oncogene.

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

H. Wathieu, E. Flemington, E. Martin, 2021, Clinical and Translational Oncology.

MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity

Ranlu Liu, Guangyu Sun, T. Chang, 2023, Journal of cancer research and clinical oncology.

Long noncoding RNA MEG3 regulates cell proliferation and apoptosis by disrupting microRNA-9-5p-mediated inhibition of NDRG1 in prostate cancer

Ranlu Liu, Jing Li, T. Chang, 2024, Aging.